Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      GranuFlo, Xarelto, and Morcellator Lawsuits Continue to Rise Due to Complications, Says Lawsuitsettlementnews.com

      Lawsuit website reports side effects and injuries due to products listed above as well as recalls. Lawsuit help center looks to assist potential plaintiffs involved in GranuFlo, Xarelto, and/or Morcellator litigations.


      News provided by

      MT Services LLC

      Jan 22, 2015, 05:00 ET

      Share this article

      Share this article


      BOCA RATON, Fla., Jan. 22, 2015 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today a primary focus on assisting potential plaintiffs who have dealt with complications as a result of GranuFlo, Xarelto, and/or Morcellator products.

      GranuFlo and NaturaLyte are chemical dialysis products that are used in dialysis machines to help clean the blood of patients with kidney malfunctions. The products were designed to prevent dangerous acid buildup in the kidneys; however, recent lawsuits against them claim that the ingredients may also increase the risk of cardiac arrest and/or various cardiovascular problems. Serious side effects include: heart attack, cardiopulmonary arrest, cardiovascular death, and stroke. In March of 2012, The U.S. FDA issued a recall of GranuFlo and NaturaLyte products, which the FDA has now declared as a Class I Recall. Currently, there are over 2,000 cases against Fresenius Medical Care Inc., and they have been consolidated into multidistrict litigation (MDL) in Massachusetts Federal Court under U.S. District Judge Douglas P. Woodlock. The first trial is scheduled for January of 2016 with the next trial set to take place a month later (February 2016). Patients, or their family members, who have had a cardiac event in a Fresenius or DaVita Dialysis Center could be awarded large sums of money if the GranuFlo product was defective. Lawsuitsettlementnews.com can provide you with immediate access to a qualified GranuFlo law firm or lawyer that will provide you with a free legal consultation.

      Simply log onto: http://www.lawsuitsettlementnews.com/granuflo-and-naturalyte-dialysis-products

      Xarelto is one of the most recent blood thinners on the market. According to Drug Watch, it was initially approved in 2011 and is manufactured by Bayer and is marketed by Johnson & Johnson's subsidiary, Janssen Pharmaceuticals. Dangerous side effects include: internal bleeding, intestinal bleeding, rectal bleeding, blood clots, embolism, brain hemorrhaging, and death caused by uncontrolled bleeding. Hundreds of lawsuits have been filed over blood thinners, including not only Xarelto but Pradaxa as well, and they have been consolidated into multidistrict litigation (MDL). Pradaxa cases have recently settled for an average settlement amount of over $150K, though many cases with serious injuries have recovered substantially more. Lawsuitsettlementnews.com believes patients with Xarelto claims could see settlement amounts in a similar range.

      To apply for a free legal consultation from a Xarelto law firm or Xarelto lawyer, please visit: http://www.lawsuitsettlementnews.com/pradaxa-all-blood-thinner-cases

      Morcellators have been used in a range of laparoscopic surgeries, including hysterectomy and myomectomy procedures and laparoscopic spleen and renal surgeries. Although the morcellator device provides a less-invasive surgery and quicker recovery time, there have been reports of the following potential side effects: spread of malignant tissue, advanced-stage cancerous growths, and metastatic leiomyosarcoma (an aggressive uterine cancer). With as many as 50,000 surgeries a year involving morcellation of fibroids, Johnson & Johnson is a market leader in morcellation device sales. Several lawsuits have already been filed against Johnson & Johnson relating to the power morcellation devices. Among those who have already filed are patients who were diagnosed with advanced stage cancer following the procedure with the morcellation device. Johnson & Johnson is also facing thousands of lawsuits over their faulty hip and pelvic mesh devices. While the cases are still very new, Johnson & Johnson is contesting liability. It is vitally important that potential plaintiffs of Morcellator cases seek qualified attorneys who have expertise in these cases. Lawsuitsettlementnews.com can assist you with obtaining a free legal consultation on your Morcellator case from a Morcellator law firm or Morcellator attorney.

      For more information, please visit: http://www.lawsuitsettlementnews.com/morcellator-lawsuit-news

      Chris Janish, CEO of MTS, commented on the recent increase of filed lawsuits over these products, "With the recent lawsuit filings on all of these cases, we now believe that all of these litigations will pick up steam and continue to grow in class size. All of the litigations have serious side effects and if the defendants are found liable at trial they could face substantial financial losses. We are adding these three products to our expanding list of mass tort litigation services that we are providing to patients and plaintiffs who need lawsuit funding, surgical funding, or a free legal consultation if they have yet to file a lawsuit claim."

      MT Services LLC provides up-to-date lawsuit news on GranuFlo, Xarelto, and Morcellator cases as well as various services to assist victims with getting the help they need during this difficult time. These services include: lawsuit pre-settlement funding cash advances, corrective or revision surgery procedure funding (or cash needs related to your surgery), and assistance with obtaining an attorney from a nationally recognized GranuFlo, Xarelto, or Morcellator law firm. MTS' lawsuit funding contacts are providing up to $50K in pre-settlement funding today on GranuFlo, Xarelto, and Morcellator cases. (Lawsuit funding or surgical funding products should not be considered to be a lawsuit loan, lawsuit loans, settlement loans, pre-settlement loans, or lawsuit settlement loans.) 

      To learn more about the lawsuit help services that MTS can provide involving the GranuFlo, Xarelto, and Morcellator cases, visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services

      If you, or a loved one, have been injured by GranuFlo, Xarelto, or a Morcellator product and need lawsuit help, including finding a law firm, obtaining pre-settlement lawsuit funding, or obtaining surgical funding, call right now to speak to a live agent at 877.571.0405. You may also fill out a quick application online at: www.lawsuitsettlementnews.com and an agent will contact you shortly.

      MT Services LLC is not a law firm and cannot provide legal advice on your case; however, MTS works with lawyers involved in mass tort litigations who are willing to provide a free legal consultation at the consumer's request. For a list of full disclosures please visit the company's website disclosure page at: http://www.lawsuitsettlementnews.com/terms-of-service

      Contact: 

      Chris Janish, CEO


      Ph. 877.571.0405

      SOURCE MT Services LLC

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.